| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8224263 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 7 Pages |
Abstract
Overall outcomes were excellent, particularly for patients with estrogen receptor-positive disease. Patients in this study with triple-negative breast cancer had a significantly higher IBTR rate than patients with other receptor phenotypes when treated with 3D-APBI. Larger, prospective 3D-APBI clinical trials should continue to evaluate the effect of hormone receptor phenotype on IBTR rates.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Itai M. MD, Abram MD, Marek PhD, Elena MD, Rita F. MD, Helen A. MD, Antonin MD, Jennifer Y. MD, Ariel E. MD, Lisa A. MD, Saveli PhD, Michelle MD, Michelle MD, Barbara L. MD, PhD, Simon N. MD, PhD, Alphonse G. MD, PhD,